These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17037313)

  • 21. Insulin resistance and blood pressure.
    Addison S; Stas S; Hayden MR; Sowers JR
    Curr Hypertens Rep; 2008 Aug; 10(4):319-25. PubMed ID: 18625163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual renin-angiotensin system blockade and kidney disease.
    Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Pfeffer MA
    J Am Coll Cardiol; 2009 Jul; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Not Available].
    Vrtovsnik F; Fartoux L
    Nephrol Ther; 2016 Dec; 12(7S):S10-S11. PubMed ID: 28132669
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical pathology and treatment of renin-angiotensin system 2. Chronic kidney disease and the renin-angiotensin system.
    Kimura G
    Intern Med; 2007; 46(16):1295-8. PubMed ID: 17704608
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross talk of tumor necrosis factor-alpha and the renin-angiotensin system in tumor necrosis factor-alpha-induced plasminogen activator inhibitor-1 production from hepatocytes.
    Takeshita Y; Takamura T; Ando H; Hamaguchi E; Takazakura A; Matsuzawa-Nagata N; Kaneko S
    Eur J Pharmacol; 2008 Jan; 579(1-3):426-32. PubMed ID: 18078928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
    Shimamoto K; Miura T
    Intern Med; 2007; 46(16):1303-4. PubMed ID: 17704610
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of renin-angiotensin system inhibitors after coronary interventions in patients with the guideline-based indications: A report from a Japanese multicenter registry.
    Ikemura N; Sawano M; Miyata H; Ueda I; Numasawa Y; Noma S; Suzuki M; Momiyama Y; Maekawa Y; Fukuda K; Kohsaka S
    Int J Cardiol; 2016 Dec; 225():362-364. PubMed ID: 27756042
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of the renin angiotensin hormonal system in the metabolic syndrome and type 2 diabetes.
    Nosadini R; Tonolo G
    Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):88-93. PubMed ID: 15242241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 38. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
    Ponticelli C; Cucchiari D
    J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.